Table 2.
Details of adverse drug reactions (ADRs)/ adverse drug events (ADEs).
| Experimental group | Control group | No grouping | |
|---|---|---|---|
| TRQ+WM vs. WM | 20 cases: Fever, 8 cases; pruritus, 3 cases; nausea, 2 cases; vomiting, 2 cases; nausea and vomiting, 2 cases, popular rash, 2 cases; diarrhea, 1 case |
23 cases: Nausea and vomiting, 9 cases; dizziness, 4 cases; diarrhea, 4 cases; vomiting, 3 cases; nausea, 2 cases; chest pain, 1 case |
10 cases: Pain due to fluid dropping too fast, 3 cases; nausea, 4 cases; dizziness, 1 case; headache, 1 case; loss of appetite, 1 case |
| XBJ+WM vs. WM | 6 cases: Vasculitis, 3 cases; skin rash, 1 case; pruritus, 1 case; flushing, 1 case |
0 | / |
| DH+WM vs. WM | 4 cases: Dizziness and flushing, 2 cases; elevated ALT, 2 cases |
4 cases: Elevated ALT, 4 cases |
/ |
| SM+WM vs. WM | 8 cases: Stimulation in oropharynx, 3 cases; palpitation, 2 cases; nystagmus, 2 cases; skin rash, 1 case |
5 cases: Palpitation, 2 cases; nystagmus, 1 case; stimulation in oropharynx, 1 case; skin rash, 1 case |
Mild headache, pruritus, skin rash and gastrointestinal adverse reactions |
| RDN+WM vs. WM | 7 cases: Gastrointestinal adverse reactions, 3 cases; skin rash, 2 cases; dizziness, chest congestion and dry mouth, 2 cases |
11 cases: Gastrointestinal adverse reactions, 6 cases; skin rash, 5 cases |
/ |
| CXQ+WM vs. WM | 1 case: Minor allergy, 1 case |
0 | / |
| XYP+WM vs. WM | 1 case: Diarrhea, 1 case |
0 | / |
| SF+WM vs. WM | 1 case: Pruritus, 1 case |
0 | / |
| XXN+WM vs. WM | 13 cases: Abdominal distension and nausea, 8 cases; dry mouth, 5 cases |
0 | / |
| SMI+WM vs. WM | 5 cases: Gastrointestinal adverse reactions, 1 case; non-specific adverse reactions, 4 cases |
5 cases: Gastrointestinal adverse reactions, 2 cases; non-specific adverse reactions, 3 cases |
/ |
| TRQ+WM vs. XYP+WM | 0 | 2 cases: Phlebitis, 2 cases |
/ |